41 results
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
several functions: to shield the brain from toxic substances (including viruses, bacteria and other foreign substances including many drugs
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
24 Oct 23
Regulation FD Disclosure
4:18pm
the brain from toxic substances (including viruses, bacteria and other foreign substances including many drugs); to supply brain tissues with nutrients
8-K
EX-10.1
x4ckdfpv9nsmq3ri
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.1
i5f 5puv45h
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
kojc6
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
khfg5vfdbe1fn3lncaaz
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
qrw9jy bpyuzmr
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
r372 crhwpt3ys58iq
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
vjn6a9l73qwxdvz59v2
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
a0yw10jgiuxgqy
7 Apr 22
Prospectus supplement
4:46pm
S-3
ungqghq55r ej9l
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
gdwuvh90aylcnyx0b3i1
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
3qyf3s0kfa
24 Sep 21
Annual report
7:31am
10-K
b0u5l1xzzr1d4phk05
24 Sep 21
Annual report
7:31am